UPDATE: Shortly after this alert was published, the Supreme Court granted an administrative stay of the Fifth Circuit’s order. This means that, while the Supreme Court reviews Danco’s and GenBioPro’s emergency requests that the Fifth Circuit’s stay be vacated, mifepristone is available under the 2023 REMS, which permits dispensing of mifepristone directly to patients by certain…Read More
Fifth Circuit Court of Appeals Panel Grants Stay in Case Challenging FDA Regulation of Mifepristone
Posted on May 4, 2026 in Health Law News
Published by: Hall Render